Generics and Biosimilars; A Step Towards Sustainable and Low Cost Health Care.

Generics and Biosimilars; A Step Towards Sustainable and Low Cost Health Care.

Gupta, Puneeta;Khan, Mehvish;
The Journal of the Association of Physicians of India 2019 Vol. 67 pp. 66-67
257
gupta2019genericsthe

Abstract

Millions of people across the globe go without essential medicines resulting in many avoidable deaths each year. It's no secret that the cost of prescription drugs, including the life-saving ones has been rising far faster than inflation over the last few years. If we take the example of diabetes and as India has the largest number of patients with the condition in the world; it has been shown that patients belonging to the low income group in urban India were spending. 27% of their annual income and those in rural India 34% of their annual income on diabetes care; most of which was spent on purchase of medicines. This raises the question of whether current pricing of drugs is based on reasonable expectation of return on investment or whether it is based on what prices the market can bear. The price of pharmaceuticals has become an issue of great concern for people and governments around the world. Thus governments across the globe must make efforts to correct the present distortions around the concept of generic drugs.

Access

Citation

ID: 69232
Ref Key: gupta2019genericsthe
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
69232
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet